Table 2.
Geographic region | Model 1a |
Model 2b |
Model 3c |
||||||
---|---|---|---|---|---|---|---|---|---|
Hazard ratio | CI | P value | Hazard ratio | CI | P value | Hazard ratio | CI | P value | |
Large fringe metro (suburban) | Reference | Reference | Reference | Reference | Reference | Reference | Reference | Reference | Reference |
Large central metro (inner city) | |||||||||
0-1 years | 0.84 | 0.52-1.34 | .5 | 0.92 | 0.57-1.49 | .7 | 0.84 | 0.50-1.43 | .5 |
≥1 years | 0.99 | 0.74-1.32 | > .9 | 1.02 | 0.76-1.37 | .9 | 0.84 | 0.61-1.17 | .3 |
Medium/small metro | |||||||||
0-1 years | 1.05 | 0.69-1.61 | .8 | 1.19 | 0.77-1.82 | .4 | 0.88 | 0.55-1.40 | .6 |
≥1 years | 1.03 | 0.79-1.36 | .8 | 1.14 | 0.86-1.51 | .4 | 0.74 | 0.54-1.01 | .06 |
Rural | |||||||||
0-1 years | 1.67 | 0.93-3.01 | .09 | 1.80 | 0.98-3.31 | .06 | 0.87 | 0.39-1.91 | .7 |
≥ 1 years | 1.0 | 0.62-1.60 | > .9 | 1.18 | 0.73-1.92 | .5 | 0.79 | 0.47-1.35 | .4 |
Unadjusted analysis.
Adjusted for individual-level covariates: age, gender, race/ethnicity, COPD diagnosis, smoking history, antifibrotic use.
Adjusted for individual-level characteristics and pulmonary function at time of referral: age, gender, race/ethnicity, COPD diagnosis, smoking history, antifibrotic use, FVC % predicted with the use of the Global Lung Initiative “Other” reference equation, diffusion capacity for carbon monoxide percent predicted with the use of the Global Lung Initiative reference equation.